The role of MALAT1 and UCA1 long non‐coding RNAs on the prognosis of patients with glioblastoma: A systematic review and meta‐analysis

Abstract Glioblastoma multiforme (GBM) is a common central nervous system malignancy with poor survival despite new treatments. Although some evidence demonstrated the prognostic effects of metastasis‐associated lung adenocarcinoma transcript 1 (MALAT1) and urothelial carcinoma associated 1 (UCA1) l...

Full description

Saved in:
Bibliographic Details
Main Authors: Sedighe Hooshmandi, Ehsan Jangholi, Amirreza Heidarian, Mahsa Dehghani, Ali Ghassemi, Aida Heidary, Ali Rezvanimehr, Erfan Sadeghi, Seyed Mohammad Ghodsi, Mohammad Hoseinian, Mostafa Farzin, Hamid Zaferani Arani, Mahmoudreza Hadjighassem
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:Precision Medical Sciences
Subjects:
Online Access:https://doi.org/10.1002/prm2.70003
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850166657924726784
author Sedighe Hooshmandi
Ehsan Jangholi
Amirreza Heidarian
Mahsa Dehghani
Ali Ghassemi
Aida Heidary
Ali Rezvanimehr
Erfan Sadeghi
Seyed Mohammad Ghodsi
Mohammad Hoseinian
Mostafa Farzin
Hamid Zaferani Arani
Mahmoudreza Hadjighassem
author_facet Sedighe Hooshmandi
Ehsan Jangholi
Amirreza Heidarian
Mahsa Dehghani
Ali Ghassemi
Aida Heidary
Ali Rezvanimehr
Erfan Sadeghi
Seyed Mohammad Ghodsi
Mohammad Hoseinian
Mostafa Farzin
Hamid Zaferani Arani
Mahmoudreza Hadjighassem
author_sort Sedighe Hooshmandi
collection DOAJ
description Abstract Glioblastoma multiforme (GBM) is a common central nervous system malignancy with poor survival despite new treatments. Although some evidence demonstrated the prognostic effects of metastasis‐associated lung adenocarcinoma transcript 1 (MALAT1) and urothelial carcinoma associated 1 (UCA1) long non‐coding RNAs (lncRNAs) in patients with GBM, a comprehensive study has not yet evaluated the clinical importance of these lncRNAs. Hence, this review aimed to predict the significance of expressions of MALAT and UCA1 lncRNAs in patients with GBM. Using proper keywords, a thorough literature search was performed via databases, including PubMed, Web of Knowledge, Scopus, and EMBASE until December 2024. The relationship between lncRNA expressions and overall survival (OS) in patients with GBM was assessed using hazard ratios (HR) and confidence intervals (95% CI), and the fixed and random effects models were used to estimate the pooled effect size. Also, the Newcastle‐Ottawa Quality Assessment Scale was used as an appraisal tool. Among 1553 initially founded records, 13 studies were enrolled in the final analysis, consisting of 915 and 257 samples in the MALAT1 and UCA1 groups, respectively. Compared to the patients with low expression, those with high expression of MALAT1 had a mortality risk of 80% (HR = 1.8, 95% CI = [1.39, 2.33], p = .001). Additionally, the impact of UCA1 expression on patient prognosis indicated that lower OS among patients was correlated with high expression of UCA1; however, the meta‐analysis was not performed for UCA1 due to a lack of adequate studies. According to our findings, high expression of MALAT1 was correlated with poor prognosis in patients with GBM.
format Article
id doaj-art-e09ebf99bd4b436283f90f9532fb20b6
institution OA Journals
issn 2642-2514
language English
publishDate 2025-06-01
publisher Wiley
record_format Article
series Precision Medical Sciences
spelling doaj-art-e09ebf99bd4b436283f90f9532fb20b62025-08-20T02:21:24ZengWileyPrecision Medical Sciences2642-25142025-06-01142667410.1002/prm2.70003The role of MALAT1 and UCA1 long non‐coding RNAs on the prognosis of patients with glioblastoma: A systematic review and meta‐analysisSedighe Hooshmandi0Ehsan Jangholi1Amirreza Heidarian2Mahsa Dehghani3Ali Ghassemi4Aida Heidary5Ali Rezvanimehr6Erfan Sadeghi7Seyed Mohammad Ghodsi8Mohammad Hoseinian9Mostafa Farzin10Hamid Zaferani Arani11Mahmoudreza Hadjighassem12Medical Imaging Research Center, Department of Radiology Shiraz University of Medical Sciences Shiraz IranBrain and Spinal Cord Injury Research Center, Neuroscience Institute Tehran University of Medical Sciences Tehran IranDepartment of Radiology Shohada Hospital, Shahid Beheshti University of Medical Sciences Tehran IranFaculty of Medicine Islamic Azad University, Tehran Medical Sciences Branch Tehran IranFaculty of Medicine Islamic Azad University, Tehran Medical Sciences Branch Tehran IranFaculty of Medicine Islamic Azad University, Tehran Medical Sciences Branch Tehran IranFaculty of Medicine Islamic Azad University, Tehran Medical Sciences Branch Tehran IranDepartment of Biostatistics School of Medicine, Shiraz University of Medical Sciences Shiraz IranBrain and Spinal Cord Injury Research Center, Neuroscience Institute Tehran University of Medical Sciences Tehran IranBrain and Spinal Cord Injury Research Center, Neuroscience Institute Tehran University of Medical Sciences Tehran IranBrain and Spinal Cord Injury Research Center, Neuroscience Institute Tehran University of Medical Sciences Tehran IranDepartment of Surgery Shiraz University of Medical Sciences Shiraz IranBrain and Spinal Cord Injury Research Center, Neuroscience Institute Tehran University of Medical Sciences Tehran IranAbstract Glioblastoma multiforme (GBM) is a common central nervous system malignancy with poor survival despite new treatments. Although some evidence demonstrated the prognostic effects of metastasis‐associated lung adenocarcinoma transcript 1 (MALAT1) and urothelial carcinoma associated 1 (UCA1) long non‐coding RNAs (lncRNAs) in patients with GBM, a comprehensive study has not yet evaluated the clinical importance of these lncRNAs. Hence, this review aimed to predict the significance of expressions of MALAT and UCA1 lncRNAs in patients with GBM. Using proper keywords, a thorough literature search was performed via databases, including PubMed, Web of Knowledge, Scopus, and EMBASE until December 2024. The relationship between lncRNA expressions and overall survival (OS) in patients with GBM was assessed using hazard ratios (HR) and confidence intervals (95% CI), and the fixed and random effects models were used to estimate the pooled effect size. Also, the Newcastle‐Ottawa Quality Assessment Scale was used as an appraisal tool. Among 1553 initially founded records, 13 studies were enrolled in the final analysis, consisting of 915 and 257 samples in the MALAT1 and UCA1 groups, respectively. Compared to the patients with low expression, those with high expression of MALAT1 had a mortality risk of 80% (HR = 1.8, 95% CI = [1.39, 2.33], p = .001). Additionally, the impact of UCA1 expression on patient prognosis indicated that lower OS among patients was correlated with high expression of UCA1; however, the meta‐analysis was not performed for UCA1 due to a lack of adequate studies. According to our findings, high expression of MALAT1 was correlated with poor prognosis in patients with GBM.https://doi.org/10.1002/prm2.70003glioblastoma multiformlong non‐coding RNAMALATsurvivalUCA1
spellingShingle Sedighe Hooshmandi
Ehsan Jangholi
Amirreza Heidarian
Mahsa Dehghani
Ali Ghassemi
Aida Heidary
Ali Rezvanimehr
Erfan Sadeghi
Seyed Mohammad Ghodsi
Mohammad Hoseinian
Mostafa Farzin
Hamid Zaferani Arani
Mahmoudreza Hadjighassem
The role of MALAT1 and UCA1 long non‐coding RNAs on the prognosis of patients with glioblastoma: A systematic review and meta‐analysis
Precision Medical Sciences
glioblastoma multiform
long non‐coding RNA
MALAT
survival
UCA1
title The role of MALAT1 and UCA1 long non‐coding RNAs on the prognosis of patients with glioblastoma: A systematic review and meta‐analysis
title_full The role of MALAT1 and UCA1 long non‐coding RNAs on the prognosis of patients with glioblastoma: A systematic review and meta‐analysis
title_fullStr The role of MALAT1 and UCA1 long non‐coding RNAs on the prognosis of patients with glioblastoma: A systematic review and meta‐analysis
title_full_unstemmed The role of MALAT1 and UCA1 long non‐coding RNAs on the prognosis of patients with glioblastoma: A systematic review and meta‐analysis
title_short The role of MALAT1 and UCA1 long non‐coding RNAs on the prognosis of patients with glioblastoma: A systematic review and meta‐analysis
title_sort role of malat1 and uca1 long non coding rnas on the prognosis of patients with glioblastoma a systematic review and meta analysis
topic glioblastoma multiform
long non‐coding RNA
MALAT
survival
UCA1
url https://doi.org/10.1002/prm2.70003
work_keys_str_mv AT sedighehooshmandi theroleofmalat1anduca1longnoncodingrnasontheprognosisofpatientswithglioblastomaasystematicreviewandmetaanalysis
AT ehsanjangholi theroleofmalat1anduca1longnoncodingrnasontheprognosisofpatientswithglioblastomaasystematicreviewandmetaanalysis
AT amirrezaheidarian theroleofmalat1anduca1longnoncodingrnasontheprognosisofpatientswithglioblastomaasystematicreviewandmetaanalysis
AT mahsadehghani theroleofmalat1anduca1longnoncodingrnasontheprognosisofpatientswithglioblastomaasystematicreviewandmetaanalysis
AT alighassemi theroleofmalat1anduca1longnoncodingrnasontheprognosisofpatientswithglioblastomaasystematicreviewandmetaanalysis
AT aidaheidary theroleofmalat1anduca1longnoncodingrnasontheprognosisofpatientswithglioblastomaasystematicreviewandmetaanalysis
AT alirezvanimehr theroleofmalat1anduca1longnoncodingrnasontheprognosisofpatientswithglioblastomaasystematicreviewandmetaanalysis
AT erfansadeghi theroleofmalat1anduca1longnoncodingrnasontheprognosisofpatientswithglioblastomaasystematicreviewandmetaanalysis
AT seyedmohammadghodsi theroleofmalat1anduca1longnoncodingrnasontheprognosisofpatientswithglioblastomaasystematicreviewandmetaanalysis
AT mohammadhoseinian theroleofmalat1anduca1longnoncodingrnasontheprognosisofpatientswithglioblastomaasystematicreviewandmetaanalysis
AT mostafafarzin theroleofmalat1anduca1longnoncodingrnasontheprognosisofpatientswithglioblastomaasystematicreviewandmetaanalysis
AT hamidzaferaniarani theroleofmalat1anduca1longnoncodingrnasontheprognosisofpatientswithglioblastomaasystematicreviewandmetaanalysis
AT mahmoudrezahadjighassem theroleofmalat1anduca1longnoncodingrnasontheprognosisofpatientswithglioblastomaasystematicreviewandmetaanalysis
AT sedighehooshmandi roleofmalat1anduca1longnoncodingrnasontheprognosisofpatientswithglioblastomaasystematicreviewandmetaanalysis
AT ehsanjangholi roleofmalat1anduca1longnoncodingrnasontheprognosisofpatientswithglioblastomaasystematicreviewandmetaanalysis
AT amirrezaheidarian roleofmalat1anduca1longnoncodingrnasontheprognosisofpatientswithglioblastomaasystematicreviewandmetaanalysis
AT mahsadehghani roleofmalat1anduca1longnoncodingrnasontheprognosisofpatientswithglioblastomaasystematicreviewandmetaanalysis
AT alighassemi roleofmalat1anduca1longnoncodingrnasontheprognosisofpatientswithglioblastomaasystematicreviewandmetaanalysis
AT aidaheidary roleofmalat1anduca1longnoncodingrnasontheprognosisofpatientswithglioblastomaasystematicreviewandmetaanalysis
AT alirezvanimehr roleofmalat1anduca1longnoncodingrnasontheprognosisofpatientswithglioblastomaasystematicreviewandmetaanalysis
AT erfansadeghi roleofmalat1anduca1longnoncodingrnasontheprognosisofpatientswithglioblastomaasystematicreviewandmetaanalysis
AT seyedmohammadghodsi roleofmalat1anduca1longnoncodingrnasontheprognosisofpatientswithglioblastomaasystematicreviewandmetaanalysis
AT mohammadhoseinian roleofmalat1anduca1longnoncodingrnasontheprognosisofpatientswithglioblastomaasystematicreviewandmetaanalysis
AT mostafafarzin roleofmalat1anduca1longnoncodingrnasontheprognosisofpatientswithglioblastomaasystematicreviewandmetaanalysis
AT hamidzaferaniarani roleofmalat1anduca1longnoncodingrnasontheprognosisofpatientswithglioblastomaasystematicreviewandmetaanalysis
AT mahmoudrezahadjighassem roleofmalat1anduca1longnoncodingrnasontheprognosisofpatientswithglioblastomaasystematicreviewandmetaanalysis